Aurobindo Pharma与一家开发呼吸道药物的全球公司结成伙伴,投资高达90万澳元。 Aurobindo Pharma partners with a global firm to develop respiratory drugs, investing up to $90M.

印度制药商Aurobindo Pharma与一家大型全球制药公司合作开发和销售呼吸道药物。 Aurobindo Pharma, an Indian drugmaker, has teamed up with a major global pharmaceutical company to develop and sell respiratory drugs. Aurobindo将支付多达9 000万美元的开发费用,两家公司将分享销售权。 Aurobindo will pay up to $90 million for development costs, and both companies will share marketing rights. 无名合伙人将处理制造业。 The unnamed partner will handle manufacturing. 这一合作旨在加速产品推出,加强奥罗宾多的药物供应。 This collaboration aims to speed up product launches and enhance Aurobindo's drug offerings.